{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:27:25Z","timestamp":1787066845886,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006827","name":"Florida Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Redox Biology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.redox.2020.101440","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T02:37:45Z","timestamp":1579747065000},"page":"101440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to \u03b2-lapachone"],"prefix":"10.1016","volume":"30","author":[{"given":"Laura","family":"Torrente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Prieto-Farigua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Falzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cody M.","family":"Elkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Boothman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Haura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina M.","family":"DeNicola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.redox.2020.101440_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030420","article-title":"Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer","volume":"3","author":"Singh","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.redox.2020.101440_bib2","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature11404","article-title":"Comprehensive genomic characterization of squamous cell lung cancers","volume":"489","author":"Network","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.redox.2020.101440_bib3","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1158\/1078-0432.CCR-09-3352","article-title":"Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features","volume":"16","author":"Solis","year":"2010","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.redox.2020.101440_bib4","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1074\/jbc.M300931200","article-title":"Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression","volume":"278","author":"McMahon","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2020.101440_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1365-2443.2003.00640.x","article-title":"Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles","volume":"8","author":"Itoh","year":"2003","journal-title":"Gene Cell."},{"key":"10.1016\/j.redox.2020.101440_bib6","doi-asserted-by":"crossref","first-page":"6334","DOI":"10.1128\/MCB.00630-07","article-title":"Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2","volume":"27","author":"Sun","year":"2007","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.redox.2020.101440_bib7","doi-asserted-by":"crossref","first-page":"13568","DOI":"10.1073\/pnas.0806268105","article-title":"Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy","volume":"105","author":"Shibata","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2020.101440_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.molcel.2006.01.013","article-title":"Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer","volume":"21","author":"Padmanabhan","year":"2006","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2020.101440_bib9","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.celrep.2016.08.010","article-title":"Recurrent loss of NFE2L2 Exon 2 is a mechanism for Nrf2 pathway activation in human cancers","volume":"16","author":"Goldstein","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.redox.2020.101440_bib10","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/0008-5472.CAN-07-5003","article-title":"Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth","volume":"68","author":"Ohta","year":"2008","journal-title":"Canc. Res."},{"key":"10.1016\/j.redox.2020.101440_bib11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","article-title":"Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2","volume":"29","author":"Wang","year":"2008","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.redox.2020.101440_bib12","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1089\/ars.2010.3219","article-title":"Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance","volume":"13","author":"Singh","year":"2010","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2020.101440_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0076-6879(90)86122-C","article-title":"DT-diaphorase: purification, properties, and function","volume":"186","author":"Lind","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.redox.2020.101440_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0891-5849(00)00300-2","article-title":"Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen","volume":"29","author":"Dinkova-Kostova","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2020.101440_bib15","first-page":"7483","article-title":"Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells","volume":"50","author":"Siegel","year":"1990","journal-title":"Canc. Res."},{"key":"10.1016\/j.redox.2020.101440_bib16","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1021\/bi00149a019","article-title":"Bioreductive activation of mitomycin C by DT-diaphorase","volume":"31","author":"Siegel","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2020.101440_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0006-2952(95)00223-5","article-title":"Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin","volume":"51","author":"Beall","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.redox.2020.101440_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0026-895X(25)08965-5","article-title":"Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity","volume":"42","author":"Gibson","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.redox.2020.101440_bib19","first-page":"7293","article-title":"Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells","volume":"50","author":"Siegel","year":"1990","journal-title":"Canc. Res."},{"key":"10.1016\/j.redox.2020.101440_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jso.24624","article-title":"Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer","volume":"116","author":"Beg","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.redox.2020.101440_bib21","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1073\/pnas.0702176104","article-title":"An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone","volume":"104","author":"Bey","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2020.101440_bib22","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1158\/0008-5472.CAN-11-3135","article-title":"An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis","volume":"72","author":"Huang","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.redox.2020.101440_bib23","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1074\/jbc.275.8.5416","article-title":"NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity","volume":"275","author":"Pink","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2020.101440_bib24","doi-asserted-by":"crossref","first-page":"19150","DOI":"10.1074\/jbc.M100730200","article-title":"Calcium is a key signaling molecule in beta-lapachone-mediated cell death","volume":"276","author":"Tagliarino","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2020.101440_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12885-015-1227-8","article-title":"NQO1 protein expression predicts poor prognosis of non-small cell lung cancers","volume":"15","author":"Li","year":"2015","journal-title":"BMC Canc."},{"key":"10.1016\/j.redox.2020.101440_bib26","first-page":"2065","article-title":"Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors","volume":"4","author":"Siegel","year":"1998","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.redox.2020.101440_bib27","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.ccell.2016.11.006","article-title":"Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly(ADP-ribose) polymerase inhibitors","volume":"30","author":"Huang","year":"2016","journal-title":"Canc. Cell"},{"key":"10.1016\/j.redox.2020.101440_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1042\/bj20030754","article-title":"Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence","volume":"374","author":"Nioi","year":"2003","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2020.101440_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbrc.2008.06.004","article-title":"Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues","volume":"373","author":"Wang","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.redox.2020.101440_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4161\/epi.6.6.15773","article-title":"Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer","volume":"6","author":"Muscarella","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.redox.2020.101440_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature10189","article-title":"Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis","volume":"475","author":"DeNicola","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.redox.2020.101440_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-3002(62)90997-6","article-title":"DT diaphorase. I. Purification from the soluble fraction of rat-liver cytoplasm, and properties","volume":"58","author":"Ernster","year":"1962","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.redox.2020.101440_bib33","doi-asserted-by":"crossref","first-page":"6372","DOI":"10.1021\/bi0600087","article-title":"The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol","volume":"45","author":"Asher","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.redox.2020.101440_bib34","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/febs.14051","article-title":"Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1)","volume":"284","author":"Lienhart","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.redox.2020.101440_bib35","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00008571-200208000-00009","article-title":"Implication of alternative splicing for expression of a variant NAD(P)H:quinone oxidoreductase-1 with a single nucleotide polymorphism at 465C>T","volume":"12","author":"Pan","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.redox.2020.101440_bib36","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41416-018-0278-4","article-title":"Phase 1 study of ARQ 761, a beta-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis","volume":"119","author":"Gerber","year":"2018","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.redox.2020.101440_bib37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1042\/bj20031049","article-title":"Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products","volume":"378","author":"Levonen","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2020.101440_bib38","doi-asserted-by":"crossref","first-page":"11908","DOI":"10.1073\/pnas.172398899","article-title":"Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants","volume":"99","author":"Dinkova-Kostova","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.redox.2020.101440_bib39","doi-asserted-by":"crossref","first-page":"6204","DOI":"10.1038\/onc.2017.221","article-title":"Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses","volume":"36","author":"Torrente","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.redox.2020.101440_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/srep17066","article-title":"Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, beta-lapachone","volume":"5","author":"Chakrabarti","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.redox.2020.101440_bib41","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1535-7163.MCT-12-0962","article-title":"Catalase abrogates beta-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers","volume":"12","author":"Bey","year":"2013","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.redox.2020.101440_bib42","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1016\/S0021-9258(18)35980-5","article-title":"Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine)","volume":"254","author":"Griffith","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.redox.2020.101440_bib43","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.freeradbiomed.2010.12.015","article-title":"Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: implications for development of specific inhibitors","volume":"50","author":"Rackham","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.redox.2020.101440_bib44","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.bjc.6604226","article-title":"Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)","volume":"98","author":"Donate","year":"2008","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.redox.2020.101440_bib45","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1158\/1078-0432.CCR-06-0171","article-title":"Copper binding by tetrathiomolybdate attenuates angiogenesis and tumor cell proliferation through the inhibition of superoxide dismutase 1","volume":"12","author":"Juarez","year":"2006","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.redox.2020.101440_bib46","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1089\/ars.2017.7201","article-title":"Identification of an unfavorable immune signature in advanced lung tumors from Nrf2-deficient mice","volume":"29","author":"Zhang","year":"2018","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.redox.2020.101440_bib47","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1172\/JCI25790","article-title":"Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis","volume":"116","author":"Thimmulappa","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2020.101440_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","article-title":"Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression","volume":"27","author":"Harris","year":"2015","journal-title":"Canc. Cell"},{"key":"10.1016\/j.redox.2020.101440_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf7444","article-title":"Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy","volume":"10","author":"Stafford","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.redox.2020.101440_bib50","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/nchembio.2499","article-title":"A CRISPR screen identifies a pathway required for paraquat-induced cell death","volume":"13","author":"Reczek","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.redox.2020.101440_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1172\/JCI71714","article-title":"Targeting SOD1 reduces experimental non-small-cell lung cancer","volume":"124","author":"Glasauer","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.redox.2020.101440_bib52","doi-asserted-by":"crossref","first-page":"e1599","DOI":"10.1038\/cddis.2014.564","article-title":"NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by beta-lapachone","volume":"6","author":"Moore","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.redox.2020.101440_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40170-015-0137-1","article-title":"Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ss-lapachone","volume":"3","author":"Chakrabarti","year":"2015","journal-title":"Canc. Metabol."},{"key":"10.1016\/j.redox.2020.101440_bib54","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1158\/0008-5472.CAN-09-3995","article-title":"Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy","volume":"70","author":"Blanco","year":"2010","journal-title":"Canc. Res."},{"key":"10.1016\/j.redox.2020.101440_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/S0959-8049(14)70379-X","article-title":"A Phase 1 correlative study of ARQ761, a \u03b2-lapachone analogue that promotes NQ01-mediated programmed cancer cell necrosis","volume":"50","author":"Gerber","year":"2014","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.redox.2020.101440_bib56","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s10637-016-0414-z","article-title":"Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species","volume":"35","author":"Lundberg","year":"2017","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.redox.2020.101440_bib57","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S2468-1253(18)30009-8","article-title":"Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial","volume":"3","author":"Jonker","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.redox.2020.101440_bib58","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/fon-2018-0903","article-title":"CanStem111P trial: a Phase III study of napabucasin plus nab-paclitaxel with gemcitabine","volume":"15","author":"Sonbol","year":"2019","journal-title":"Future Oncol."},{"key":"10.1016\/j.redox.2020.101440_bib59","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1158\/1078-0432.CCR-19-0302","article-title":"Bioactivation of napabucasin triggers reactive oxygen species-mediated cancer cell death","volume":"25","author":"Froeling","year":"2019","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.redox.2020.101440_bib60","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/ng.3421","article-title":"NRF2 regulates serine biosynthesis in non-small cell lung cancer","volume":"47","author":"DeNicola","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.redox.2020.101440_bib61","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ccell.2016.06.022","article-title":"High-throughput phenotyping of lung cancer somatic mutations","volume":"30","author":"Berger","year":"2016","journal-title":"Canc. Cell"},{"key":"10.1016\/j.redox.2020.101440_bib62","article-title":"Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer","volume":"8","author":"Kang","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.redox.2020.101440_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2018.01.017","article-title":"Combinatorial CRISPR-Cas9 metabolic screens reveal critical redox control points dependent on the KEAP1-NRF2 regulatory Axis","volume":"69","author":"Zhao","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.redox.2020.101440_bib64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/BJ20090242","article-title":"Mitochondrial peroxiredoxin 3 is more resilient to hyperoxidation than cytoplasmic peroxiredoxins","volume":"421","author":"Cox","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.redox.2020.101440_bib65","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Canc. Discov."},{"key":"10.1016\/j.redox.2020.101440_bib66","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.redox.2020.101440_bib67","doi-asserted-by":"crossref","first-page":"D856","DOI":"10.1093\/nar\/gku1151","article-title":"MethHC: a database of DNA methylation and gene expression in human cancer","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res."}],"container-title":["Redox Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231719314326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213231719314326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:11:59Z","timestamp":1761977519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213231719314326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":67,"alternative-id":["S2213231719314326"],"URL":"https:\/\/doi.org\/10.1016\/j.redox.2020.101440","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/849927","asserted-by":"object"}]},"ISSN":["2213-2317"],"issn-type":[{"value":"2213-2317","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to \u03b2-lapachone","name":"articletitle","label":"Article Title"},{"value":"Redox Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redox.2020.101440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101440"}}